Phosphoproteomic profiling of the signaling output of FLT3-ITD and its 
AC220-resistant mutants reveals profound signaling differences and differential 
responsiveness to inhibition of downstream kinases.

Doebele, C.; Kovar, J.; Yepes, D.; Münch, S.; Schnütgen, F.; Bohnenberger, H.; Köhler, A.; Urlaub, H.; Serve, H.; Oellerich, T.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Conference Paper

Phosphoproteomic profiling of the signaling output of FLT3-ITD and its AC220-resistant mutants reveals profound signaling differences and differential responsiveness to inhibition of downstream kinases.

MPS-Authors

/persons/resource/persons15947

Urlaub, H.
Research Group of Bioanalytical Mass Spectrometry, MPI for biophysical chemistry, Max Planck Society;

External Resource

http://www.bloodjournal.org/content/126/23
(Publisher version)

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Doebele, C., Kovar, J., Yepes, D., Münch, S., Schnütgen, F., Bohnenberger, H., et al. (2015). Phosphoproteomic profiling of the signaling output of FLT3-ITD and its AC220-resistant mutants reveals profound signaling differences and differential responsiveness to inhibition of downstream kinases. Blood, 126(23): 2453.

Cite as: http://hdl.handle.net/11858/00-001M-0000-0029-D35A-1

Abstract

There is no abstract available